to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Commercializing a medical device that's clinically superior is not enough in today's economic climate. Medical device companies need to market products that have both clinical and economic value, says the CEO of Medtronic.
There's stability and then there's outright growth. For healthcare business owners looking for angel funding, they'll have to accept the former and wait some more on the latter. But at least it's progress.
The number of healthcare venture deals is at its lowest level in at least five quarters, according to a new report. However, healthcare seed investment hit a record high in the same quarter.
How can healthcare CEOs train the next generation of company leaders? One study suggests training is best done with a healthy dose of no-nonsense straight talk in a one-on-one setting.
There is no shortage of well-educated people in academic environments. But the challenge is in turning the attention of those bright minds to entrepreneurship. Here are a few ideas on how to do it.
In a venture funding climate seeking large returns, thousands of potentially successful entrepreneurial startups can't get the financing they need to make a difference in the economy and in the culture. The problem isn't a new one, but it is a damaging one.
The FDA needs a chief innovation officer to help the agency stay informed about the latest technological advances, says the head of the biotechnology industry's leading trade group. Read more about what he has to say on the FDA and FDA reform.
Can "boom and bust" cycles exist in the venture funding market? You bet they can. And recent data from the chemical sector is a great example of how and why.
At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
